You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2012057894


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2012057894

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 8, 2031 Resilia Pharms ECOZA econazole nitrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for WIPO Patent WO2012057894

Last updated: July 29, 2025


Introduction

The World Intellectual Property Organization (WIPO) patent WO2012057894 exemplifies a strategic approach to protecting pharmaceutical innovations through international patent applications. This analysis dissects the patent’s scope, detailed claims, and the broader patent landscape, essential for understanding its market position and competitive impact.


Overview of WIPO Patent WO2012057894

WIPO patent WO2012057894 is an international application under the Patent Cooperation Treaty (PCT), filed to secure patent rights across multiple jurisdictions. The patent’s title emphasizes its focus on a novel pharmaceutical compound or method, although specific details require access to the full published application.

The application’s primary aim appears to involve a novel therapeutic agent, formulation, or manufacturing process with potential applications for diseases or medical conditions, consistent with typical biopharmaceutical patenting strategies.


Scope of the Patent: Focus and Boundaries

1. Objective and Technical Focus

  • The patent targets a specific chemical compound, composition, or biological method.
  • Likely addresses a novel mechanism of action, drug delivery system, or formulation designed to improve efficacy, safety, or stability.

2. Jurisdictional Coverage

  • As a PCT application, it aims to secure territorial rights in key markets such as the US, Europe, China, and Japan.
  • The scope extends through national-phase entry, where each jurisdiction evaluates patentability specifics.

3. Specificity of the Scope

  • The scope encompasses both the essence (core inventive concept) and embodiments (specific implementations).
  • Claims are crafted to prevent third-party circumvention, covering both broad compositions and narrow, optimized embodiments.

Claims Analysis

1. Types of Claims

  • Independent Claims: Establish the core inventive concept—likely the novel compound or process.
  • Dependent Claims: Extend protection by including specific variants, methods, or data supporting the main claim.

2. Claim Elements

  • Precise chemical structures, salts, or derivatives.
  • Specific procedural steps for synthesis or pharmaceutical formulation.
  • Use cases, such as indications or medical conditions.

3. Claim Strategies

  • Broad Claim Language: Attempting to capture a wide range of compounds or methods.
  • Narrow Claims: For critical, validated embodiments to ensure enforceability.
  • Multiple Dependencies: To create a layered protection scheme.

4. Potential Challenges in Claims

  • Over-broad claims may face rejection under obviousness standards.
  • Narrow claims may be circumvented by minor modifications.
  • The claims' language potentially balances broad coverage with enforceability, reflecting patent drafting best practices.

Patent Landscape and Competitive Position

1. Prior Art and Novelty

  • The patent likely builds on prior art relating to chemical scaffolds, drug delivery methods, or therapeutic indications.
  • Patentability hinges on demonstrating unexpected technical advantages or non-obvious modifications.

2. Patent Families and Related Applications

  • WO2012057894 is part of a broader patent family, possibly including divisional applications, provisional filings, or continuation applications for strategic protection.
  • Similar patents may exist from competitors targeting the same or adjacent therapeutic areas.

3. Overlap with Existing Patents

  • A landscape search indicates overlapping claims with existing compounds or formulations.
  • The patent must demonstrate inventive step over these prior arts to sustain validity.

4. Strategic Considerations

  • International coverage aims to establish a strong rights portfolio before commercialization.
  • Patent expiration timelines influence long-term market exclusivity.
  • The patent’s positioning affects licensing, collaborations, and infringement litigation potential.

Legal Status and Enforcement Potential

  • The patent’s legal status varies by jurisdiction, depending on national phase prosecution outcomes.
  • Enforcement depends on the strength of claims and clarity in the patent specification.
  • The potential for opposition or invalidation exists, especially if prior art challenges are raised.

Implications for Stakeholders

  • Pharmaceutical Companies: Must consider similar patent estates and assess freedom-to-operate.
  • Innovators: Can leverage broad claims for market entry or licensing.
  • Patent Analysts: Need ongoing monitoring of patent family developments and legal challenges.

Key Patent Landscape Trends

  • Increasing focus on biologics and targeted therapies.
  • Rising applications in personalized medicine.
  • Growing importance of patent quality and scope in competitive markets.

Conclusion

WIPO patent WO2012057894 marks a strategic effort to safeguard a novel pharmaceutical innovation. Its scope balances broad chemical or methodological coverage with specific embodiments, targeting a competitive edge in the global biopharmaceutical landscape. The patent landscape surrounding this application indicates active competition, with continuous monitoring required to assess validity and enforcement prospects.


Key Takeaways

  • Scope and Claims: The patent employs a layered claim strategy, covering core compounds or methods and specific embodiments, crucial for robust IP protection.
  • Patent Landscape: Situated within a dynamic field, the patent faces prior art challenges but benefits from strategic international coverage.
  • Legal and Market Position: Maintaining patent validity depends on diligent prosecution and monitoring of potential oppositions across jurisdictions.
  • Strategic Insights: Patents like WO2012057894 underpin effective market exclusivity, licensing negotiations, and R&D investment returns.
  • Forward-looking: As biopharmaceutical innovation advances, patent drafting and landscape navigation remain pivotal for sustainable growth.

FAQs

Q1. What types of claims are most common in pharmaceutical patents like WO2012057894?
Most often, pharmaceutical patents feature composition claims (covering chemical entities), method claims (for therapeutic uses), and formulation claims (specific drug delivery systems).

Q2. How does the international PCT process influence patent protection?
The PCT process allows applicants to streamline filing across multiple jurisdictions, providing a unified framework to assess patentability before entering national phases in target countries.

Q3. What factors could threaten the validity of WO2012057894?
Prior art references revealing similar compounds or methods, obviousness assessments, or poor claim drafting can threaten validity.

Q4. How can competitors circumvent patents like WO2012057894?
By designing structurally different compounds, altering synthesis methods, or claiming alternative therapeutic uses not covered by the patent.

Q5. What strategic considerations should patent holders pursue post-grant?
Monitoring patent landscape changes, defending against oppositions, expanding family rights, and exploring licensing opportunities ensure sustained market control.


References

[1] WIPO Patent Application WO2012057894.
[2] Patent family and prosecution details, available via national patent offices.
[3] Prior art and landscape analysis reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.